SC-VC-PAB-N-Me-L-Ala-Maytansinol

Fmoc-N-Me-L-Ala-maytansinol

N-Me-L-Ala-maytansinol

Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine

SC-VC-PAB-DM1

SC-VC-PAB-MMAE

(3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-6-ethyl-15-(4-hydroxy-benzyl)-12-(1H-indol-3-ylmethyl)-1,18-dimethyl-1,4,7,10,13,16-hexaaza-cyclooctadecane-2,5,8,11,14,17-hexaone

5-(5-Bromopyridin-3-yl)-3-phenyl-1,2,4-oxadiazole

[(1-methyl-1H-pyrazol-5-yl)methyl][3-(morpholin-4-yl)propyl]amine

(3-methoxypropyl)[(1-methyl-1H-pyrazol-5-yl)methyl]amine

hexyl[(1-methyl-1H-pyrazol-5-yl)methyl]amine

6-ethoxy-N-(2-hydroxypropyl)-2-naphthalenesulfonamide

2-Methyl-2-{[(1-methyl-1H-pyrazol-5-yl)methyl]amino}propan-1-ol

4-Amino-4-(2,5-difluorophenyl)butanoic acid

2-Iodo-N-((1-methyl-1h-pyrazol-5-yl)methyl)aniline

Cyclohexanebutanoic acid, alpha-hydroxy-beta-((2-((4-(4-(methylamino)-1-piperidinyl)-1,4-dioxo-2-(phenylmethyl)butyl)amino)-3-(methylthio)-1-oxopropyl)amino)-, 1-methylethyl ester, (alphaR-(alphaR*,betaS*(R*(R*))))-

Camptothecin 20-propionate monohydrate